PRE
Price
$5.20
Change
-$0.00 (-0.00%)
Updated
May 8, 03:46 PM (EDT)
Capitalization
51.51M
SHC
Price
$13.23
Change
+$0.08 (+0.61%)
Updated
May 8 closing price
Capitalization
3.31B
89 days until earnings call
Ad is loading...

PRE vs SHC

Header iconPRE vs SHC Comparison
Open Charts PRE vs SHCBanner chart's image
Prenetics Global
Price$5.20
Change-$0.00 (-0.00%)
Volume$469
Capitalization51.51M
Sotera Health
Price$13.23
Change+$0.08 (+0.61%)
Volume$1.01M
Capitalization3.31B
PRE vs SHC Comparison Chart
Loading...
SHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRE vs. SHC commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRE is a Buy and SHC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (PRE: $5.19 vs. SHC: $13.23)
Brand notoriety: PRE and SHC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PRE: 59% vs. SHC: 74%
Market capitalization -- PRE: $51.51M vs. SHC: $3.31B
PRE [@Medical Specialties] is valued at $51.51M. SHC’s [@Medical Specialties] market capitalization is $3.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRE’s FA Score shows that 1 FA rating(s) are green whileSHC’s FA Score has 1 green FA rating(s).

  • PRE’s FA Score: 1 green, 4 red.
  • SHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PRE is a better buy in the long-term than SHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHC’s TA Score shows that 5 TA indicator(s) are bullish.

  • SHC’s TA Score: 5 bullish, 5 bearish.

Price Growth

PRE (@Medical Specialties) experienced а -0.76% price change this week, while SHC (@Medical Specialties) price change was +9.34% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.41%. For the same industry, the average monthly price growth was +9.32%, and the average quarterly price growth was -3.40%.

Reported Earning Dates

PRE is expected to report earnings on Mar 12, 2024.

SHC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.41% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHC($3.32B) has a higher market cap than PRE($51.5M). SHC has higher P/E ratio than PRE: SHC (65.11) vs PRE (0.97). SHC YTD gains are higher at: -3.289 vs. PRE (-10.517). SHC has higher annual earnings (EBITDA): 407M vs. PRE (-12.29M). SHC has more cash in the bank: 296M vs. PRE (68.8M). PRE has less debt than SHC: PRE (5.26M) vs SHC (2.33B). SHC has higher revenues than PRE: SHC (1.05B) vs PRE (280M).
PRESHCPRE / SHC
Capitalization51.5M3.32B2%
EBITDA-12.29M407M-3%
Gain YTD-10.517-3.289320%
P/E Ratio0.9765.111%
Revenue280M1.05B27%
Total Cash68.8M296M23%
Total Debt5.26M2.33B0%
TECHNICAL ANALYSIS
Technical Analysis
SHC
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Declines
ODDS (%)
Bearish Trend 18 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Ad is loading...
SHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PINRX14.65N/A
N/A
Principal Diversified Intl R3
VIVIX65.39N/A
N/A
Vanguard Value Index I
JIAGX9.03N/A
N/A
JHancock Multi-Asset High Income C
IHOFX19.97N/A
N/A
Hartford International Opportunities F
ALCEX13.50N/A
N/A
Avantis U.S. Large Cap Value G